News & Analysis on Clinical Trial Services & Contract Research And Development
VirtualScopics reported a breakthrough year in 2005, doubling its customer base to 26 and reaping in more than $5 m (€4.1 m) worth of business, an increase from the previous year of over 100 per cent.
Researchers are looking into the possibility of using a protein that undesirably shields a skin poxvirus from the immune system as the key ingredient in a new topical treatment for inflammatory diseases.
AIDS researchers have uncovered new evidence, which points to the 'fitness' of the HIV virus as a primary factor in explaining different resistant patterns to the drugs that treat the disease.
Sigma Aldrich has launched a new integrated lysis and affinity purification (iLAP) column, which greatly simplifies the process of cell lysis and histidine-tagged protein purification into one step, allowing fast, efficient and non-denaturing protein...
Hill Top Research, one of the leading clinical research services companies in the US, has positioned itself for growth after last week's acquisition by Utah's DW Healthcare Partners, a private equity firm focused on the healthcare industry.
A new report reveals that a lack of validation amongst drug discovery processes has emerged as a major restraint to the uptake and penetration levels of computational biology tools in the drug discovery industry.
ADME/toxicity service providers, Cyprotex, launch a new service to help drug discovery groups assess new oral drug candidates. The service will equip researchers with new pharmacokinetic insights as early as possible, aiming to improve on similar...
UK's In2Focus Healthcare Technologies has formed a strategic alliance with Canadian based IsaiX Technologies, to co-promote each other's IT technology services for the pharma industry in Europe and North America.